Nonviral Gene Delivery to the Lateral Ventricles in Rat Brain: Initial Evidence for Widespread Distribution and Expression in the Central Nervous System
Open Access
- 1 March 2001
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 3 (3), 375-384
- https://doi.org/10.1006/mthe.2001.0272
Abstract
The use of DNA for nonviral gene expression depends on several factors. These include (i) delivery and accessibility to the targeted tissue, (ii) protection from extracellular degradation, (iii) sufficient uptake by cells of interest, and (iv) protection from intracellular degradation to allow translation of adequate levels of intracellular or secreted proteins. As an initial step in demonstrating the feasibility of nonviral, cationic lipid-mediated gene therapy, we present evidence for the successful delivery and expression of heat shock protein Hsp70 and reporter gene enzymes in the central nervous system (CNS) of the rat after injection into the lateral ventricle. Gene delivery is accomplished using optimized formulations of plasmid DNA, which have been complexed with the cationic lipid MLRI. Results from DNA vectors encoding for green fluorescent protein (GFP), luciferase, and Hsp70 are reported. Standard immunofluorescent methods were used to demonstrate widespread expression of the reporter proteins and of Hsp70. Stereology analysis has been completed on three coronal sections, which illustrates the distribution of expression along the longitudinal axis. These initial findings support the further development of nonviral, lipid-mediated gene delivery technology for transient expression of protective, intracellular proteins and represent an important step leading to in vivo studies to identify potential clinical benefits.This publication has 48 references indexed in Scilit:
- Synthetic DNA delivery systemsNature Biotechnology, 2000
- Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trialsNature Medicine, 1999
- Inflammatory responses and their impact on β-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleusGene Therapy, 1999
- Liposome-mediated NGF gene transfection following neuronal injury: potential therapeutic applicationsGene Therapy, 1999
- ADVANCES IN SELF-LIMITED GENE EXPRESSION OF PROTECTIVE INTRACELLULAR PROTEINS IN-VIVO IN RAT BRAIN USING mRNA / CATIONIC LIPID COMPLEXESAnesthesia & Analgesia, 1998
- Considerations for the Design of Improved Cationic Amphiphile-Based Transfection ReagentsJournal of Liposome Research, 1996
- Improved Cationic Lipid Formulations for In Vivo Gene TherapyAnnals of the New York Academy of Sciences, 1995
- A flexible approach to synthetic lipid ammonium salts for polynucleotide transfectionTetrahedron Letters, 1995
- In vivo and ex vivo gene transfer to the brainCurrent Opinion in Neurobiology, 1994
- [43] Cationic liposome-mediated RNA transfectionMethods in enzymology, 1993